Clinical Trials Logo

Filter by:
NCT ID: NCT02198651 Completed - Clinical trials for Rheumatoid Arthritis

A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects

PREDICTRA
Start date: January 5, 2015
Phase: Phase 4
Study type: Interventional

The primary objective of the study was to investigate the association between residual disease activity at Baseline as detected by Magnetic Resonance Imaging (MRI) and the occurrence of flares in participants with rheumatoid arthritis (RA) randomized to an adalimumab dose tapering regimen controlled by adalimumab withdrawal.

NCT ID: NCT02198495 Completed - Clinical trials for Anemia of Chronic Kidney Disease

Comparison Study of Two Iron Compounds for Treatment of Anemia in Hemodialysis Patients

COPEFER
Start date: September 2014
Phase: Phase 4
Study type: Interventional

Patients with end-stage kidney disease on maintenance hemodialysis frequently require iron supplementation to compensate for ongoing iron losses, and to maintain hemoglobin levels with or without additional use of erythropoiesis-stimulating agents (ESA). The investigators aim to compare two different intravenous iron preparations, ferric carboxymaltose and iron sucrose in 140 hemodialysis patients. The investigators primary objective is to assess whether both agents are equally effective to maintain a target haemoglobin within 10-12 mg/dl. The investigators will also measure ferritin, transferrin, transferrin saturation, and how much ESA therapy is administered. Patients will be randomly assigned to either treatment group and followed in parallel over an active study period of 40 weeks.

NCT ID: NCT02197416 Completed - Clinical trials for Venous Thromboembolism

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Start date: September 29, 2014
Phase: Phase 3
Study type: Interventional

This open-label, single arm prospective cohort study will assess the safety of dabigatran etexilate in secondary prevention of venous thromboembolism in paediatric patients. Children from 0 to less than 18 years of age will be eligible to participate.

NCT ID: NCT02194985 Completed - Fabry Disease Clinical Trials

Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease

Start date: March 14, 2015
Phase: Phase 3
Study type: Interventional

This is an open-label extension study intended to provide continued treatment with migalastat hydrochloride (HCl) for participants with Fabry disease who completed treatment of a previous migalastat HCl study. The study assessed the long-term safety and effectiveness of migalastat HCl.

NCT ID: NCT02190188 Completed - Clinical trials for Partial Meniscectomy

The Influence of Wedge Insoles After Partial Meniscectomy

Start date: March 2014
Phase: N/A
Study type: Interventional

Research on the implications of orthotic devices and the recovery after knee arthroscopy are widely known. But only a handful of specific issues have been studied to date. However, the effect of orthotic devices on the recovery after partial meniscectomy are largely unknown. To our best knowledge, there are no studies that deal with the treatment of partial medial or lateral meniscectomy with wedge insoles, valgus or varus knee braces. The purpose of this study is to find out if using wedge inserts or knee orthoses improve the outcomes after partial meniscectomy. We therefore verify the following hypothesis: In patients with partial meniscectomy can be by the postoperative use of exculpatory wedge deposits or relieving knee brace achieve a significantly better clinical outcome than without specific treatment.

NCT ID: NCT02187471 Completed - Clinical trials for Pain Associated With Fibromyalgia

Treatment of Pain Associated With Fibromyalgia

Start date: January 16, 2015
Phase: Phase 3
Study type: Interventional

The main objective of this trial is to compare change in weekly average daily pain score (ADPS) from baseline to Week 13 in participants receiving either dose of DS-5565 versus placebo. Weekly ADPS is based on daily pain scores reported by the subject that best describes his or her worst pain over the previous 24 hours.

NCT ID: NCT02187107 Completed - HIV Clinical Trials

A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study was primarily to assess the long-term safety and tolerability of TMC114/rtv in addition to an individually optimized background antiretroviral therapy in HIV-1 infected participants. In addition, antiviral activity and immunological effect were also evaluated.

NCT ID: NCT02185911 Completed - Anaemia Clinical Trials

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

ADAPTATION
Start date: June 2014
Phase: N/A
Study type: Observational

To describe anaemia correction via haemoglobin measurements taken throughout observation period in ESA naive patients with chronic kidney disease initiated on darbepoetin alfa QM

NCT ID: NCT02184416 Completed - Clinical trials for Metastatic Renal Cell Carcinoma (mRCC)

Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

ADONIS
Start date: October 31, 2014
Phase:
Study type: Observational

This is an international, multi-centre, prospective (partly retrospective), observational study to evaluate treatment patterns and clinical outcomes in patients with advanced or metastatic RCC treated with sunitinib in first line and/or receiving axitinib in second line post sunitinib. The study is designed to enroll approximately 750 patients over the course of an enrollment period of approximately 36 months.

NCT ID: NCT02182999 Completed - Hallux Valgus Clinical Trials

Continuous Wound Infiltration After Hallux Valgus Surgery

CWI-HVS
Start date: May 2014
Phase: Phase 4
Study type: Interventional

The aim of this study is to investigate the effect of continuous wound infiltration with ropivacaine in comparison to standard pain management after elective distal metatarsal osteotomy for postoperative pain control.